MYC on the Path to Cancer

Dang, Chi V.·2012·Cell
DOI 10.1016/j.cell.2012.03.003

Cited by (1,008)

Items 901–1,000 of 1,008

  1. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
    Ka Iong Chan, Siyuan Zhang, Guodong Li, Yida Xu, Liao Cui, Yitao Wang, Huanxing Su, Wen Tan, Zhangfeng Zhong · 2024 · Aging and Disease
  2. MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation
    Jian Ma, Lei Li, Bohan Ma, Tianjie Liu, Zixi Wang, Qi Ye, Yunhua Peng, Bin Wang, Yule Chen, Shan Xu et al. · 2024 · Nature Communications
  3. Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
    Mudasir A. Kumar, Sana Khurshid Baba, Inamu Rashid Khan, Mohd Shahnawaz Khan, Fohad Mabood Husain, Saheem Ahmad, Mohammad Haris, Mayank Singh, Ammira Al‐Shabeeb Akil, Muzafar Ahmad Macha et al. · 2025 · MedComm
  4. ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
    Yu Chen, Chi Zhou, Wei Ji, Zhichao Mei, Bo Hu, Wei Zhang, Dawei Zhang, Jing Wang, Xing Liu, Gang Ouyang et al. · 2016 · Nature Communications
  5. MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation
    Sarah Anderson, Kumud Raj Poudel, Minna Roh‐Johnson, Thomas Brabletz, Ming Yu, Nofit Borenstein‐Auerbach, William Grady, Jihong Bai, Cecilia B. Moens, Robert N. Eisenman et al. · 2016 · Proceedings of the National Academy of Sciences
  6. Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer
    Amanda R. Oran, Clare M. Adams, Xiao-yong Zhang, Victoria J. Gennaro, Harla K. Pfeiffer, Hestia S. Mellert, Hans E. Seidel, Kirsten Mascioli, Jordan Kaplan, Mahmoud Gaballa et al. · 2016 · Oncotarget
  7. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene
    Susanna Ambrosio, Stefano Amente, Carmen Daniela Saccà, Mario Capasso, Raffaele Calogero, Luigi Lania, Barbara Majello · 2016 · Oncotarget
  8. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer
    Xiaoxia Li, Liang Shi, Shu‐Feng Zhou, Jing Wu, Tiansong Xia, Wenbin Zhou, Xi Sun, Lei Zhu, Ji‐Fu Wei, Qiang Ding · 2017 · Journal of Experimental & Clinical Cancer Research
  9. MYC promotes cancer progression by modulating m6A modifications to suppress target gene translation
    Gongwei Wu, Caixia Suo, Ying Yang, Shengqi Shen, Linchong Sun, Shiting Li, Yingli Zhou, Dongdong Yang, Yan Wang, Yongping Cai et al. · 2021 · EMBO Reports
  10. T cells at work: How post‐transcriptional mechanisms control T cell homeostasis and activation
    Anouk P. Jurgens, Branka Popović, Monika C. Wolkers · 2021 · European Journal of Immunology
  11. Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression
    Alexey Ponomarev, Zarema Gilazieva, Valeriya V. Solovyeva, Cinzia Allegrucci, Albert Anatolyevich Rizvanov · 2022 · Cancers
  12. Cytotoxic effect of γ-sitosterol from Kejibeling (Strobilanthes crispus) and its mechanism of action towards c-myc gene expression and apoptotic pathway
    Endrini, Susi, Rahmat, Asmah, Ismail, Patimah, Taufiq-Yap, Y.H. · 2015 · Medical Journal of Indonesia
  13. KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer
    Jun Zhang, Wandong Yu, Xilong Wang, Bo Hu, Denglong Wu, Guowei Shi · 2020 · OncoTargets and Therapy
  14. Unraveling the Kinetics of Spare-Tire DNA G-Quadruplex Folding
    J. Tassilo Grün, Anja Blümler, Ines Burkhart, Julia Wirmer, Alexander Heckel, Harald Schwalbe · 2021 · Journal of the American Chemical Society
  15. Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways
    Changwu Wu, Jun Tan, Hong Shen, Chao Deng, Christian Kleber, Georg Osterhoff, Nikolas Schopow · 2024 · Journal of Biomedical Science
  16. Therapeutic Targeting of the GLS1–c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer
    Jianqiang Yang, Fanghui Chen, Liwei Lang, Fan Yang, Zhenzhen Fu, Juan Martínez, Amber Cho, Nabil F. Saba, Yong Teng · 2024 · Cancer Research
  17. STK33 promotes hepatocellular carcinoma through binding to c-Myc
    Tian Yang, Bin Song, Jin Zhang, Guang-Shun Yang, Han Zhang, Weifeng Yu, Mengchao Wu, Jun‐Hua Lu, Feng Shen · 2014 · Gut
  18. Transcriptional control of DNA replication licensing by Myc
    Taras Valovka, Manuela Schönfeld, Philipp Raffeiner, Kathrin Breuker, Theresia Dunzendorfer-Matt, Markus Hartl, Klaus Bister · 2013 · Scientific Reports
  19. MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience
    Aaron M. Udager, Martin K. Ishikawa, David Robert Lucas, Jonathan Brad McHugh, Rajiv M. Patel · 2016 · Pathology
  20. The Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics
    Sarbajeet Nagdas, David F. Kashatus · 2017 · Antioxidants
  21. Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer
    Erika S. Dahl, Katherine M. Aird · 2017 · Frontiers in Oncology
  22. CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression
    Xuhong Fu, Xiong Zhang, Hong Yang, Xiaowei Xu, Zong-long Hu, Juan Yan, Xingling Zheng, Rong-rui Wei, Zhuqing Zhang, Shi-rui Tang et al. · 2018 · Acta Pharmacologica Sinica
  23. Solution Structure of a MYC Promoter G-Quadruplex with 1:6:1 Loop Length
    Jonathan Dickerhoff, Buket Onel, Luying Chen, Yuwei Chen, Danzhou Yang · 2019 · ACS Omega
  24. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content
    Carmen Morcelle, Sandra Menoyo, Francisco D. Morón-Duran, Albert Tauler, Sara C. Kozma, George Thomas, Antonio Gentilella · 2019 · Cancer Research
  25. Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications
    Diana Reyes-Garau, Marcelo Lima Ribeiro, Gaël Roué · 2019 · Cancers
  26. Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells
    Yusuke Nakatsu, Takeshi Yamamotoya, Koji Ueda, Hiraku Ono, Masa-Ki Inoue, Yasuka Matsunaga, Akifumi Kushiyama, Hideyuki Sakoda, Midori Fujishiro, Akio Matsubara et al. · 2019 · Cancer Letters
  27. Jumonji domain‐containing protein 6 protein and its role in cancer
    Jing Yang, Siyuan Chen, Yanfei Yang, Xuelei Ma, Bin Shao, Shengyong Yang, Yuquan Wei, Xiawei Wei · 2020 · Cell Proliferation
  28. An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation
    Philipp Raffeiner, Jonathan Ross Hart, Daniel García-Caballero, Liron Bar‐Peled, Marc S. Weinberg, Peter K. Vogt · 2020 · Proceedings of the National Academy of Sciences
  29. Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2
    Liye Wang, Shuang Ying Zhou, Bin Guo · 2020 · International Journal of Molecular Sciences
  30. Drugging the ‘undruggable’. Therapeutic targeting of protein–DNA interactions with the use of computer-aided drug discovery methods
    Mariia Radaeva, Anh‐Tien Ton, Michael Hsing, Fuqiang Ban, Artem R Cherkasov · 2021 · Drug Discovery Today
  31. SLCO4A1-AS1 promotes colorectal tumourigenesis by regulating Cdk2/c-Myc signalling
    Jia Zhang, Kaisa Cui, Liuying Huang, Fan Yang, Shengbai Sun, Zehua Bian, Xue Wang, Chaoqun Li, Yuan Yin, Shengling Huang et al. · 2022 · Journal of Biomedical Science
  32. Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer
    Jia Wang, Wen-Feng Zhang, Cun Liu, Longyun Wang, Jibiao Wu, Chang-Gang Sun, Qi-Biao Wu · 2024 · International Journal on Biological Sciences
  33. c-Myc Regulates Proliferation and Fgf10 Expression in Airway Smooth Muscle after Airway Epithelial Injury in Mouse
    Thomas Volckaert, Alice Campbell, Stijn De Langhe · 2013 · PLoS ONE
  34. MYC Protein Expression in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
    Kamraan Z. Gill, FABIO MASSAITI IWAMOTO, Ashleigh Allen, Daniela Hoehn, Vundavalli V.V.S. Murty, Bachir Alobeid, Govind Bhagat · 2014 · PLoS ONE
  35. Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
    Dongdong Yang, Linchong Sun, Zhaoyong Li, Ping Gao · 2016 · Advances in experimental medicine and biology
  36. miR-451 suppresses bladder cancer cell migration and invasion via directly targeting c-Myc
    Jun Wang, Xiaomei Zhao, Jianhua Shi, Yiwei Pan, Qinghai Chen, Pengfei Leng, Yan Wang · 2016 · Oncology Reports
  37. Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth
    Lindsay C. Lustig, Dharmendra D Dingar, William B. Tu, Corey Lourenco, Manpreet Kalkat, Ichiro Inamoto, Romina Ponzielli, Warren C. W. Chan, Jumi A. Shin, Linda Z. Penn · 2017 · Oncogene
  38. Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesis
    J-L Park, Y-S Lee, S-H Hong, S-H Hong, J-H Ahn, E-H Seo, S-P Shin, SJ Lee, B H Johnson, M R Stampfer et al. · 2017 · Oncogene
  39. S6K1 phosphorylation-dependent degradation of Mxi1 by β-Trcp ubiquitin ligase promotes Myc activation and radioresistance in lung cancer
    Yumei Huang, Kaishun Hu, Sheng Zhang, Xiaorong Dong, Zhongyuan Yin, Rui Meng, Yingchao Zhao, Xiaofang Dai, Tao Zhang, Kunyu Yang et al. · 2018 · Theranostics
  40. Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer
    Zhenhua Yang, Kushani K. Shah, Theodore Busby, Keith Giles, Alireza Khodadadi‐Jamayran, Wei Li, Hao Jiang · 2018 · Journal of Clinical Investigation
  41. Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation
    Elodie Marie Da Costa, Gregory Armaos, Gabrielle McInnes, Annie Beaudry, Gaël Moquin‐Beaudry, Virginie Bertrand-Lehouillier, Maxime Caron, Chantal Richer, Pascal St-Onge, Jeffrey R. Johnson et al. · 2019 · Journal of Experimental & Clinical Cancer Research
  42. BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression
    Thomas Cummin, Kerry L. Cox, Tom Murray, Anna H. Turaj, Lisa Dunning, Vikki English, Rachel Fell, Graham Packham, Yan Ma, Ben Powell et al. · 2020 · Blood Advances
  43. TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B-cell malignancies.
    Can Li, Ji-Liang Xia, Reinaldo Franqui Machin, Fang-Ping Chen, Yan-Juan He, T. Ashby, F. Teng, Hong-Wei Xu, Ding-Xiao Liu, Dong-Zheng Gai et al. · 2021 · Journal of Clinical Investigation
  44. The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms
    Yue Teng, Li Xu · 2013 · Clinical & Experimental Metastasis
  45. ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury
    Ranran Li, Mei Meng, Ying Chen, Tingting Pan, Yinjiaozhi Li, Yunxin Deng, Ruyuan Zhang, Rui Tian, Wen Xu, Xiangtao Zheng et al. · 2023 · Cell Death and Disease
  46. Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies
    Laurence Haddadin, Xueqin Sherine Sun · 2025 · Cells
  47. The Metabolic Landscape of Cancer Stem Cells: Insights and Implications for Therapy
    Martina Milella, Monica Rutigliano, Savio Domenico Pandolfo, Achille Aveta, Felice Crocetto, Matteo Ferro, Antonio d’Amati, Pasquale Ditonno, Giuseppe Tiziano Lucarelli, Francesco M. Lasorsa · 2025 · Cells
  48. Oncogenes strike a balance between cellular growth and homeostasis
    Bo Qiu, Marie Celeste Simon · 2015 · Seminars in Cell and Developmental Biology
  49. Overexpression of MYC and EZH2 cooperates to epigenetically silence MST1 expression
    Gamze Kuser Abali, Ahmet Alptekin, Bekir Cinar · 2014 · Epigenetics
  50. Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5
    Kenji Tago, Megumi Funakoshi‐Tago, Hiroshi Itoh, Yusuke Furukawa, Jiro Kikuchi, Takaharu Kato, Koichi Suzuki, Ken Yanagisawa · 2014 · Oncogene
  51. SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer
    Mohammed A. Mansour, Toshinori Hyodo, Khondker Ayesha Akter, Toshio Kokuryo, Keisuke Uehara, Masato Nagino, Takeshi Senga · 2015 · Oncotarget
  52. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression
    Chunhua Wan, Gong Chen, Haifeng Zhang, Lu Hua, Xiaohong Li, Xudong Chen, Yinji Chen, Xiaoling Ding, Song He, Wei Cao et al. · 2016 · Cancer Letters
  53. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis
    Marcela Cristina Robaina, Roberta Soares Faccion, Luciano Mazzoccoli, Lídia Maria Magalhães de Rezende, Eduardo Queiroga, Carlos E. Bacchi, Andrei Thomas‐Tikhonenko, Claudete Esteves Klumb · 2016 · Annals of Hematology
  54. Cancer metabolism as a central driving force of glioma pathogenesis
    Kenta Masui, Webster K. Cavenee, Paul S. Mischel · 2016 · Brain Tumor Pathology
  55. MUC1-C Represses the Crumbs Complex Polarity Factor CRB3 and Downregulates the Hippo Pathway
    Maroof Alam, Audrey Bouillez, Ashujit Tagde, Rehan Ahmad, Hasan N. Rajabi, Takahiro Maeda, Masayuki Hiraki, Yozo Suzuki, Donald W. Kufe · 2016 · Molecular Cancer Research
  56. SUMO suppresses and MYC amplifies transcription globally by regulating CDK9 sumoylation
    Fang Yu, Guang W. Shi, Shimeng Cheng, Jiwei Chen, Shwu-Yuan Wu, Zhiqiang Wang, Nansong Xia, Yunhao Zhai, Zhen‐Xing Wang, Yu Peng et al. · 2018 · Cell Research
  57. Insulin and Metformin Control Cell Proliferation by Regulating TDG-Mediated DNA Demethylation in Liver and Breast Cancer Cells
    Jia-Bao Yan, Chien-Cheng Lai, Jin-Wei Jhu, Brendan Gongol, Traci Marin, Shih‐Chieh Lin, Hsiang-Yi Chiu, Chia‐Jui Yen, Liang-Yi Wang, I‐Chen Peng · 2020 · Molecular Therapy — Oncolytics
  58. An ionizable supramolecular dendrimer nanosystem for effective siRNA delivery with a favorable safety profile
    Dinesh M. Dhumal, Wenjun Lan, Ling Ding, Yifan Jiang, Zhenbin Lyu, Erik Laurini, Domenico Marson, Aura Tintaru, Nelson Dusetti, Suzanne Giorgio et al. · 2020 · Nano Research
  59. Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity
    Ophir Shani, Yael Raz, Lea Monteran, Ye’ela Scharff, Oshrat Levi-Galibov, Or Megides, Hila Shacham, Noam Cohen, Dana Silverbush, Camilla Avivi et al. · 2021 · eLife
  60. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting
    Ionica Masgras, Claudio Laquatra, Giuseppe Cannino, Stefano Artin Serapian, Giorgio Colombo, Andrea Rasola · 2021 · Seminars in Cancer Biology
  61. Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells
    Ting La, Song Chen, Tao Guo, Xiao Hong Zhao, Teng Liu, Dandan Li, Michael J. Carnell, Yuan Yuan Zhang, Yuchen Feng, Nicole Cole et al. · 2021 · Theranostics
  62. Recent advances in field effect transistor biosensor technology for cancer detection: a mini review
    Lemeng Chao, Ying Jie Liang, Xiao Hu, Huanhuan Shi, Ting Xia, Hong Zhang, Huiling Xia · 2021 · Journal of Physics D Applied Physics
  63. BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes
    Li Ma, Jianwei Wang, Yongping Zhang, Fang Fang, Jing Ling, Xinran Chu, Zimu Zhang, Yanfang Tao, Xiaolu Li, Yuanyuan Tian et al. · 2022 · Cancer Biology & Therapy
  64. Strategies to target the cancer driver MYC in tumor cells
    Leonie I. Weber, Markus Hartl · 2023 · Frontiers in Oncology
  65. NSCLC: from tumorigenesis, immune checkpoint misuse to current and future targeted therapy
    Leona Raskova Kafkova, Joanna Maria Mierzwicka, Prosenjit Chakraborty, Petr Jakubec, Ondřej Fischer, Jozef Škarda, Petr Malý, Milan Raška · 2024 · Frontiers in Immunology
  66. Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists
    Amer Mahmoud, Tracy I. George, David R. Czuchlewski, Qianyun Zhang, Carla S. Wilson, Cordelia E. Sever, Alexei Bakhirev, Dahua Zhang, Nichole L Steidler, Kaaren K. Reichard et al. · 2014 · Modern Pathology
  67. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells
    Lulu Farhana, Marcia I. Dawson, Joseph A. Fontana · 2015 · Cancer Biology & Therapy
  68. p63-Mediated activation of the β-catenin/c-Myc signaling pathway stimulates esophageal squamous carcinoma cell invasion and metastasis
    Kwang Bok Lee, Shuai Ye, Man Hee Park, Byung Hyun Park, Ju‐Seog Lee, Soo Mi Kim · 2014 · Cancer Letters
  69. BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene
    Nitesh Devinarayan Sharma, Vera Magistroni, Rocco Piazza, Stefania Citterio, Caterina Mezzatesta, Praveen Khandelwal, Alessandra Pirola, Carlo B Gambacorti-Passerini · 2015 · Molecular Cancer
  70. Using induced pluripotent stem cells as a tool for modelling carcinogenesis
    Emma L. Curry · 2015 · World Journal of Stem Cells
  71. Triptolide suppresses proliferation, hypoxia-inducible factor-1α and c-Myc expression in pancreatic cancer cells
    Xiaoling Ding, Xiaorong Zhou, Bo Jiang, Qun Zhao, Guoxiong Zhou · 2015 · Molecular Medicine Reports
  72. Mathematical models of cancer metabolism
    Elke Katrin Markert, Alexei Vázquez · 2015 · Cancer & Metabolism
  73. Epigenetic Regulation of Noncoding Rna Transcription by Mammalian Rna Polymerase III
    Jong‐Lyul Park, Yeon-Su Lee, Nawapol Kunkeaw, Seon‐Young Kim, In-Hoo Kim, Yong Sun Lee · 2017 · Epigenomics
  74. Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells
    Jingbo Zhang, Hui Xu, Xueyan Zhou, Yanyu Li, Tong Liu, Xiaoxing Yin, Bei Zhang · 2017 · Oncology Letters
  75. Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions
    Tingyu Wu, Guanghui Wang, Wei Chen, Zhehui Zhu, Yun Liu, Zhenyu Huang, Yuji Huang, Peng Du, Yili Yang, Chen‐Ying Liu et al. · 2018 · Cell Death and Disease
  76. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer
    Shuaibing Wang, Jiejie Qin, Hua Ye, Keyan Wang, Jianxiang Shi, Yan Ma, Yitao Duan, Chunhua Song, Xiao Wang, Liping Dai et al. · 2018 · OncoImmunology
  77. Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect
    Peng Luo, Chi Zhang, Fengying Liao, Long Chen, Zhenyu Liu, Lei Long, Zhongyong Jiang, Yawei Wang, Ziwen Wang, Zujuan Liu et al. · 2019 · Cell Communication and Signaling
  78. XPO1 is a critical player for bortezomib resistance in multiple myeloma: A quantitative proteomic approach
    Venkatesh Chanukuppa, Debasish Paul, Khushman Taunk, Tathagata Chatterjee, Sanjeevan Sharma, Saravanan Kumar, Manas Kumar Santra, Srikanth Rapole · 2019 · Journal of Proteomics
  79. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2
    Ji Hoon Jung, Hyo‐Jung Lee, Ju‐Ha Kim, Deok Yong Sim, Eunji Im, Sinae Kim, Suhwan Chang, Sung‐Hoon Kim · 2020 · Cells
  80. Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance
    Madeleine R. Berendsen, Wendy B.C. Stevens, Michiel van den Brand, J. Han van Krieken, Blanca Scheijen · 2020 · Cancers
  81. The immune landscape during the tumorigenesis of cervical cancer
    Yiying Wang, Mengdi He, Guodong Zhang, Kankan Cao, Moran Yang, Hongwei Zhang, Haiou Liu · 2021 · Cancer Medicine
  82. IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating β-catenin
    Yarong Guo, Jun Xu, Qiang Du, Yihe Yan, David A. Geller · 2021 · Translational Oncology
  83. Arginine methyltransferase PRMT3 promote tumorigenesis through regulating c-MYC stabilization in colorectal cancer
    Yongbo Hu, Yu‐Xiong Su, Yiming He, Wei Liu, Bin Xiao · 2021 · Gene
  84. Evolutionarily conserved transcription factors as regulators of longevity and targets for geroprotection
    Fabian Fischer, Giovanna Grigolon, Christoph Benner, Michael Ristow · 2022 · Physiological Reviews
  85. [Corrigendum] c‑Myc regulates the CDK1/cyclin B1 dependent‑G2/M cell cycle progression by histone H4 acetylation in Raji cells
    Yan Yang, Kai Xue, Zhi Li, Wei Zheng, Weijie Dong, Jiazhe Song, Shijie Sun, Tonghui Ma, Wenzhe Li · 2019 · International Journal of Molecular Medicine
  86. MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction
    Gaurav Pathria, Sachin Kumar Verma, Jun Yin, David A. Scott, Ze’ev A. Ronai · 2021 · EMBO Reports
  87. Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma
    María Victoria Ruiz-Pérez, Lourdes Sainero‐Alcolado, Ganna Oliynyk, Isabell Matuschek, Nicola Balboni, S. J. Kumari A. Ubhayasekera, Marteinn Thor Snaebjornsson, Kamil Makowski, Kristina E. Aaltonen, Daniel Bexell et al. · 2021 · iScience
  88. Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2
    Xiaoduan Li, Yi Zhang, Xinjing Wang, Feikai Lin, Xi Cheng, Xipeng Wang, Xipeng Wang · 2021 · Cell Biology and Toxicology
  89. A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
    Feifei Guo, Olga Estévez‐Vázquez, Raquel Benedé‐Ubieto, Douglas Maya‐Miles, Kang Zheng, Rocío Gallego‐Durán, Ángela Rojas, Javier Ampuero, Manuel Romero‐Gómez, Philip Kaye et al. · 2021 · Cancers
  90. Advancement of cell-penetrating peptides in combating triple-negative breast cancer
    Mahak Fatima, Mohammed A. S. Abourehab, Geeta Aggarwal, Gaurav Kumar Jain, Amirhossein Sahebkar, Prashant Kesharwani · 2022 · Drug Discovery Today
  91. The Interplay between T Cells and Cancer: The Basis of Immunotherapy
    Christina Chen, Xin Liu, Che‐Yu Chang, Helen Y. Wang, Rong‐Fu Wang · 2023 · Genes
  92. A metabolic perspective of Peto's paradox and cancer
    Chi Van Dang · 2015 · Philosophical Transactions of the Royal Society B Biological Sciences
  93. Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy
    Jing Ying Tan, Qiang Yu · 2013 · 癌症：英文版
  94. Error-prone Translesion Synthesis Past DNA-Peptide Cross-links Conjugated to the Major Groove of DNA via C5 of Thymidine
    Susith Wickramaratne, Emily J. Boldry, Charles Buehler, Yen-Chih Wang, Mark Dewey Distefano, Natalia Y. Tretyakova · 2014 · Journal of Biological Chemistry
  95. Transcription factors and chromatin proteins as therapeutic targets in cancer
    Simon J. Johnston, Jason S. Carroll · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  96. FOXO6 promotes gastric cancer cell tumorigenicity via upregulation of C‐myc
    Qinyu Li, Cui Long, Du Zhen-dong, Shi Min-min, Weize Wu, Weiping Yang, Chenghong Peng · 2013 · FEBS Letters
  97. Synthetic Lethal Vulnerabilities of Cancer
    Ferran Fece de la Cruz, Bianca V. Gapp, Sebastian M. B. Nijman · 2014 · The Annual Review of Pharmacology and Toxicology
  98. MYC Releases Early Reprogrammed Human Cells from Proliferation Pause via Retinoblastoma Protein Inhibition
    Rand, Tim A., Sutou, Kenta, Tanabe, Koji, Jeong, Daeun, Nomura, Masaki, Kitaoka, Fumiyo, Tomoda, Emi, Narita, Megumi, Nakamura, Michiko, Nakamura, Masahiro et al. · 2018 · Cell Reports
  99. A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma
    Olanich, Mary E, Barr, Frederic G · 2013 · Expert Opinion on Therapeutic Targets
  100. Glutamine deprivation counteracts hypoxia-induced chemoresistance
    Wappler, Jessica, Arts, Martijn, Röth, Anjali, Heeren, Ron M.A., Peter Neumann, Ulf, Olde Damink, Steven W., Soons, Zita, Cramer, Thorsten · 2020 · Neoplasia